Short-term Testosterone Replacement in Testicular Cancer Survivors
NCT03339635
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
32
Enrollment
OTHER
Sponsor class
Conditions
Testicular Cancer
Interventions
DRUG:
Androgel (Testosterone gel)
DRUG:
Placebo gel
Sponsor
University Medical Center Groningen